
RADX P/E Ratio
P/E Ratio as of Jul 1, 2025: -0.35
Average-0.3948
Median-0.3900
Minimum-0.4400
Maximum-0.3500
-0.35
Past Month+0.03 (7.89%)
The P/E ratio for RADX is -0.35 as of Jul 1, 2025. This represents a increase of 84.21% compared to its 12-month average P/E ratio of -0.19. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Radiopharm Theranostics Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Radiopharm Theranostics Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Radiopharm Theranostics Ltd to industry peers.
Radiopharm Theranostics Ltd P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Radiopharm Theranostics Ltd’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Radiopharm Theranostics Ltd to industry peers.
RADX P/E Ratio Insights
See Radiopharm Theranostics Ltd’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in RADX
Order type
Buy in
Order amount
Est. shares
0 shares
RADX P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $4.287 | -0.35 |
Jun 2, 2025 | $5.169 | -0.42 |
May 1, 2025 | $4.00 | -0.33 |
Apr 1, 2025 | $4.68 | -0.38 |
Mar 3, 2025 | $5.50 | -0.45 |
Feb 3, 2025 | $4.43 | -0.18 |
Jan 14, 2025 | $5.40 | -0.22 |
RADX End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.35 | — |
FAQs About Radiopharm Theranostics Ltd (RADX) P/E ratio
The latest P/E ratio of RADX is -0.35, as of Jul 1, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Radiopharm Theranostics Ltd’s last 12-month average P/E ratio is -0.19, compared to its current P/E ratio of -0.35. This reflects a increase of 84.21%.
Radiopharm Theranostics Ltd’s current P/E ratio of -0.35 is higher than its last 12-month average P/E of -0.19. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Radiopharm Theranostics Ltd’s average P/E ratio over the last 3 years is -0.06. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Radiopharm Theranostics Ltd’s average P/E ratio over the last 5 years is -0.04. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.